1. Home
  2. CADL vs EROK Comparison

CADL vs EROK Comparison

Compare CADL & EROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$9.92

Market Cap

739.2M

Sector

Health Care

ML Signal

N/A

Logo EagleRock Land LLC Class A shares representing limited liability company interests

EROK

EagleRock Land LLC Class A shares representing limited liability company interests

N/A

Current Price

$21.90

Market Cap

623.3M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
EROK
Founded
1999
2023
Country
United States
United States
Employees
55
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
739.2M
623.3M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
CADL
EROK
Price
$9.92
$21.90
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$21.75
★ $28.83
AVG Volume (30 Days)
★ 1.1M
161.9K
Earning Date
11-12-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.62
N/A
EPS
N/A
★ N/A
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
$154.84
Revenue Next Year
N/A
$17.21
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$20.06
52 Week High
$14.00
$27.42

Technical Indicators

Market Signals
Indicator
CADL
EROK
Relative Strength Index (RSI) 36.74 43.62
Support Level $9.18 $20.11
Resistance Level $10.59 $22.53
Average True Range (ATR) 0.56 0.95
MACD -0.12 0.05
Stochastic Oscillator 15.26 49.93

Price Performance

Historical Comparison
CADL
EROK

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About EROK EagleRock Land LLC Class A shares representing limited liability company interests

EagleRock Land LLC is a surface-focused land management company, focused on providing access to land, resources, and infrastructure assets in the Permian Basin, including areas in Texas and New Mexico. Its assets support oil and natural gas development, as well as activities related to power generation, water infrastructure, and other industries. Through its land position and integrated infrastructure assets, the company generates revenue and royalties from completion and production-based activities, including surface damages, ROWs, easements, commercial water supply and produced water recycling, handling and disposal and other surface and subsurface related activities.

Share on Social Networks: